Although the FSTL1 level did not vary by age, BMI, plasma TG level, free fatty acid (FFA) levels, or cholesterol levels, we observed a significant positive correlation between FSTL1 expression and liver pathologies (steatosis, ballooning, fibrosis, and NAS) (Fig. 7b–d). This evidence concerns the gene FSTL1 and steatosis.